NCT05927233View on ClinicalTrials.gov

Effect of Methylprednisolone on Systemic Inflammatory Response During Pediatric Congenital Open-Heart Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

June 30, 2025

Conditions
Cyanotic Heart DiseaseCardiopulmonary Bypass
Interventions
DRUG

Methylprednisolone

30 ml Methylprednisolone (30mg/kg) with a maximum dose of 500 mg

DRUG

Saline

30 ml Normal saline

Trial Locations (1)

74800

RECRUITING

Aga Khan University Hospital, Karachi

All Listed Sponsors
lead

Aga Khan University

OTHER